Drugs profiles

Dianabol is the brand name by which the oral steroid Methandrostenolone is known. This steroid was brought to market in the USA by CIBA in the year 1959. Dr. John Bosley Ziegler is the man responsible for creating Dianabol, his motivation was to use it as an aid for American athletes competing against the Soviets. The Russians had already been using the performance enhancing effects of testosterone in their athletes for years. After discovering this, it took the Americans until 1959 to develop their own steroid to challenge the soviet doping machine. The Russians were injecting Testosterone Suspension several times per day to increase strength and performance with great success. Dr. Ziegler would in turn developed Methandrostenolone, which would later be known as Dianabol, a much stronger hormone than Testosterone with the added benefit that it could be take orally a couple of times per day. The laboratory that sponsored Dr. Ziegler’s research CIBA released the newly created Methandrostenolone under the brand name Dianabol.

Dihydrotestosterone (DHT) is a biologically active metabolite of the hormone testosterone, formed primarily in the prostate gland, testes, hair follicles , and adrenal glands by the enzyme 5α-reductase by means of reducing the 4,5 double-bond. Dihydrotestosterone belongs to the class of compounds called androgens, also commonly called androgenic hormones or testoids. Androgens are part of the biology of gender by stimulating and controlling the development and maintenance of masculine characteristics. DHT is 3 times more potent than testosterone; testosterone is 5-10 times more potent than adrenal androgens.

Dynabolon is an inectable form of the anabolic steroid nandrolone. The ester attatched to nandrolone in Dynabolon is slightly larger than that used in Deca Durabolin, and thus causes a slightly slower release from the injection sight than does Deca. Because of this slow release, Dynaboln can be comfortably injected once every 1 to 2 weeks. Although it is no longer being made, Dynabolon was once highly sought after by athletes and bodybuilders due to its ability to promote slow, steady gains in lean muscle mass with minimal estrogen or androgen related side effects.

Boldenone Undeclynate is the chemical name of the steroid we know as Equipoise. In order to make a steroid for use in the veterinary industry, the structure of the Dianabol product changed. Since it is more efficient to inject an animal every few weeks instead of feeding it steroids daily, the hormone was modified to create a product for intramuscular injection. By adding an ester (Undeclynate) to the hormone, scientist created a product that could suspend into an oil solution while also slowing down the rate at which the hormone will be used by the body. A single injection of Equipose can slowly release and be used by the muscles for as long as six weeks after administration.
The common believe in the steroid world is that Equipoise will take up to four weeks to build up in the body before the user sees noticeable effects. It is also believed that Equipoise will taper off slowly at the end of a steroid cycle, so using Equipoise at the end will help make Post Cycle Therapy more effective.

Formebolone is an anabolic steroid which is derived from testosterone and is a close relative of the steroid dianabol, but has been extensively modified. Formebolone is unable to convert to estrogen, and exhibits even less relative androgenicity in comparison. Formebolone was first studied extensively during the 1970’s in Italy. It was developed as a steroid with increased anabolic activity and reduced androgenic activity compared to the hormone testosterone, with a focus on the tissue building functions of testosterone and reducing its unwanted side effects. Esiclene is no longer available as a prescription medication. When manufactured it was commonly found in the form of 5mg tablets and a 2mg/ml injectable solution.

Finaplix is an injectable anabolic/androgenic steroid which is derived from the the steroid nandrolone. It’s activity however is quite different to the point that direct comparisons between the two are difficult to make. Finaplix is a non estrogenic steroid and is considerably both more anabolic and androgenic than its parent nandrolone on a milligram for milligram basis. Finaplix was first extensively studied in 1967, described during a series of studies of experiments into synthetic steroids. Finaplix is a drug of veterinary medicine which is used almost exclusively to increase the rate of weight gain and improve feed efficiency of cattle shortly before slaughter. Meat products sold in many areas of the world will often contain small amounts of residual trenbolone metabolites as a result of this practice. Human users of finaplix often purchase kits which are readily available online in order to convert the implant pellets into an injectable oil solution.

Fluoxymesterone is an oral anabolic steroid which is a derivative of the hormone testosterone. Specifically, it is a methyltestosterone derivative, being different due to the addition of 11-beta-hydroxy and 9-alpha-fluoro groups. The result is a very potent orally active non aromatizable steroid that shows extremely potent androgenic properties. Halotestin is considerably more androgenic than testosterone, while the anabolic effects of this drug are considered to be moderate in comparison. Fluoxymesterone was first developed in the 1950’s. It was introduced to the US pharmaceutical market shortly after and first marketed by the company UpJohn. It was prescribed for the purposes of tissue repair, burns, delayed healing of fractures, and for males with insufficient androgen levels.

Laurabolin is an inectable form of the anabolic steroid nandrolone. The ester attatched to nandrolone in Laurabolin s slightly larger than that used in Deca Durabolin, and thus causes a slightly slower release from the injection sight than does Deca. Because of this slow release, Laurabolin can be comfortably injected once every 1 to 2 weeks. Although it is no longer being made, Laurabolin was once highly sought after by athletes and bodybuilders due to its ability to promote slow, steady gains in lean muscle mass with minimal estrogen or androgen related side effects.

Drostanolone propionate is an injectable anabolic steroid derived from dihydrostestosterone (DHT). Here, the DHT has been modified with a 2-methyl group to increase its anabolic properties, making this drug much more effective at promoting muscle growth than the non-methylated DHT. Drostanolone propionate was founded in the 1950’s. A company called Syntex developed the compound along with such other well known steroids as Anadrol and Superdrol. Around ten years later masteron drostanolone was first introduced as a prescription medication. In the US, the FDA approved drostanolone for use in postmenopausal women for the treatment of inoperable breast cancer. Eventually other prescription medications were developed which better served the same conditions that this drug was originally approved for, and slowly manufacturers began to voluntarily discontinue production of it. Now days, this drug is no longer available as a prescription drug and can only be purchased on the black market where it is still a popular compound amongst the bodybuilding and performance enhancing community.

Clostebol acetate is an anabolic steroid that is a derivative of testosterone. Clostebol is 4-chloro-testosterone, a modification that makes this drug a low strength anabolic compound with minimal androgenic potency. Clostebol acetate was first produced in 1956 and was developed into a prescription medication in Europe where it was marketed under the name Steranabol by the company Farmitalia, and the name Turinabol by a company called Jenapharm. The original medical use for this product was to treat osteoporosis, and then later was found to be successful when used to treat conditions of anorexia and certain types of liver disease. Clostebol acetate was made in both the form of oral pills and also an injectable preparation. This drug was widely used with females and elderly patients due to the mild anabolic nature of it. Although quite favorable in effect and the comfort of use, clostebol acetate was never really successful as an anabolic and saw only limited use in a small number of markets. Eventually all manufacturers of this product ceased production of the injectable and oral forms of the compound. Although the injectable version of this product are now off the markets, clostebol acetate is still manufactured by a number of companies in the form of a dermal preparation. The most popular brand of this product is produced in Italy. The dermal preparations of this steroid are usually used in the treatment of wounds and ulcers.